Brendan M Everett Selected Research

canakinumab

12/2021	Canakinumab's Effect Against Subsequent Gout Flares and High-Sensitivity C-Reactive Protein Levels: A Causal Mediation Analysis.
10/2020	Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial.
1/2020	Targeting Inflammation to Reduce Residual Cardiovascular Risk.
1/2019	Novel Antiatherosclerotic Therapies.
1/2019	Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
1/2019	Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.
10/2018	Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
10/2018	Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
1/2018	Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.
1/2018	Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan M Everett Research Topics

Disease

26	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2009
17	Myocardial Infarction 10/2020 - 06/2011
16	Type 2 Diabetes Mellitus (MODY) 11/2021 - 09/2009
14	Inflammation (Inflammations) 10/2020 - 07/2010
9	Stroke (Strokes) 11/2021 - 12/2006
8	Heart Failure 01/2022 - 12/2014
8	Thrombosis (Thrombus) 12/2021 - 02/2007
5	Atherosclerosis 01/2019 - 01/2009
4	Coronary Disease (Coronary Heart Disease) 01/2019 - 08/2006
4	Atrial Fibrillation 04/2014 - 07/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 08/2013
3	Acute Coronary Syndrome 01/2020 - 08/2015
3	Diabetes Mellitus 01/2019 - 06/2011
3	Peripheral Arterial Disease 01/2019 - 01/2018
3	Hypertension (High Blood Pressure) 01/2016 - 04/2008
3	Ischemic Stroke 01/2016 - 12/2006
3	Thrombocytopenia (Thrombopenia) 02/2007 - 08/2006
2	Gout 12/2021 - 10/2018
2	COVID-19 08/2021 - 08/2021
2	Critical Illness (Critically Ill) 08/2021 - 08/2021
2	Rheumatoid Arthritis 01/2020 - 08/2013
2	Dyslipidemias (Dyslipidemia) 01/2019 - 12/2018
2	Unstable Angina 10/2018 - 01/2018
2	Infections 10/2017 - 01/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015 - 08/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Hypertriglyceridemia 12/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 10/2018
1	Chronic Renal Insufficiency 01/2018
1	Insulin Resistance 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Sepsis (Septicemia) 10/2017

Drug/Important Bio-Agent (IBA)

16	C-Reactive ProteinIBA 12/2021 - 12/2006
13	canakinumab FDA Link 12/2021 - 01/2017
11	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2006
9	LipidsIBA 01/2020 - 12/2006
8	TroponinIBA 01/2021 - 02/2015
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2010
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 03/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2009
5	Heparin (Liquaemin)FDA LinkGeneric 08/2021 - 08/2006
5	InterleukinsIBA 10/2020 - 01/2009
5	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 10/2014
5	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 08/2013
5	Monoclonal AntibodiesIBA 01/2019 - 01/2017
5	LDL CholesterolIBA 01/2019 - 12/2006
5	Troponin T (Troponin T1)IBA 10/2018 - 06/2011
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2018
4	Natriuretic PeptidesIBA 01/2022 - 03/2013
4	HDL CholesterolIBA 01/2020 - 12/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2009
4	Rosuvastatin Calcium (Crestor)FDA Link 05/2015 - 01/2010
3	SodiumIBA 01/2022 - 11/2021
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020 - 12/2017
3	Troponin IIBA 01/2020 - 05/2015
3	InflammasomesIBA 12/2019 - 10/2017
3	CholesterolIBA 01/2019 - 12/2006
3	oxidized low density lipoproteinIBA 12/2018 - 12/2006
3	AntibodiesIBA 02/2007 - 08/2006
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 10/2018
2	CanagliflozinIBA 01/2020 - 01/2018
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 12/2018
2	ApolipoproteinsIBA 01/2019 - 05/2009
2	Insulin Glargine (Lantus)FDA Link 12/2017 - 09/2009
2	Metformin (Glucophage)FDA LinkGeneric 12/2017 - 09/2009
2	Insulin (Novolin)FDA Link 12/2017 - 09/2009
2	Genetic Markers (Genetic Marker)IBA 04/2014 - 08/2013
2	Lipoprotein(a)IBA 02/2014 - 05/2009
2	Platelet Factor 4IBA 08/2006 - 08/2006
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	Colchicine FDA LinkGeneric 01/2020
1	SolutionsIBA 01/2020
1	EnzymesIBA 01/2019
1	PPAR alphaIBA 12/2018
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 12/2018
1	Uric Acid (Urate)IBA 10/2018
1	trans-crotonin (CTN)IBA 01/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Sodium-Glucose Transport ProteinsIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2017
1	NLR ProteinsIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017

Therapy/Procedure

12	Therapeutics 11/2021 - 04/2008
3	Secondary Prevention 01/2019 - 08/2013
2	Aftercare (After-Treatment) 12/2018 - 10/2018
2	Glycemic Control 12/2017 - 09/2009
1	Critical Care (Surgical Intensive Care) 08/2021
1	Surgical Amputation (Amputations) 01/2020